BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20233817)

  • 1. Screening and detection of breast cancer and prostate cancer.
    Saloustros E; Mavroudis D
    JAMA; 2010 Mar; 303(11):1032; author reply 1033-4. PubMed ID: 20233817
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Ponti A; Rosso S; Zanetti R; Ricceri F; Tomatis M; Segnan N
    J Natl Cancer Inst; 2007 Dec; 99(23):1817-8; author reply 1819. PubMed ID: 18042935
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Chu DZ
    J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Anderson BO
    J Natl Cancer Inst; 2007 Dec; 99(23):1815-6; author reply 1816-7. PubMed ID: 18042937
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Byers T; Trujillo S; Hines L
    J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast cancer trends: a marriage between clinical trial evidence and epidemiology.
    Berry DA; Ravdin PM
    J Natl Cancer Inst; 2007 Aug; 99(15):1139-41. PubMed ID: 17652274
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics.
    Welch HG; Gorski DH; Albertsen PC
    N Engl J Med; 2015 Oct; 373(18):1685-7. PubMed ID: 26510017
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characterization of the hormone dependence of breast neoplasms using mammography. Prospectives and limitations].
    Frigerio A; Burke P; Fasciano F; Temporelli A
    Minerva Ginecol; 1987; 39(7-8):525-32. PubMed ID: 3670703
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent trends in breast cancer incidence rates in the Loire-Atlantique, France: a decline since 2003.
    Fontenoy AM; Leux C; Delacour-Billon S; Allioux C; Frenel JS; Campone M; Molinié F
    Cancer Epidemiol; 2010 Jun; 34(3):238-43. PubMed ID: 20409772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Vaidya JS
    J Natl Cancer Inst; 2008 Apr; 100(8):598-9; author reply 599. PubMed ID: 18398100
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast cancer decline mirrors fall in hormone use, spurs both debate and research.
    McNeil C
    J Natl Cancer Inst; 2007 Feb; 99(4):266-7. PubMed ID: 17312300
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
    Robbins AS; Clarke CA
    J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938
    [No Abstract]   [Full Text] [Related]  

  • 16. Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications.
    Anderson WF; Chu KC; Devesa SS
    Breast Cancer Res Treat; 2004 Nov; 88(2):149-59. PubMed ID: 15564798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for early detection of breast cancer: overdiagnosis versus suboptimal patient management.
    Gur D; Sumkin JH
    Radiology; 2013 Aug; 268(2):327-8. PubMed ID: 23882095
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
    Séradour B; Allemand H; Weill A; Ricordeau P
    Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the effectiveness of a mammography screening service.
    Clayforth C; Fritschi L; McEvoy S; Byrne MJ; Wylie E; Threlfall T; Sterrett G; Harvey JM; Jamrozik K
    ANZ J Surg; 2005 Aug; 75(8):631-6. PubMed ID: 16076321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammograms and ER in patients with breast cancer.
    Elliott RL
    South Med J; 1991 Jan; 84(1):102-3. PubMed ID: 1986418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.